RARA CRAFT DATABASE for FDA Medical Devices
PMAP960058S167

FDA DEVICE FACTS

HiResolution™ Bionic Ear System

Advanced Bionics

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEJuly 22, 2026PRODUCT CODEMCM

Indications for use

The HiResolution™ Bionic Ear System is intended to restore a level of auditory sensation to individuals with severe-to-profound sensorineural hearing loss via electrical stimulation of the auditory nerve. Bilateral Hearing Loss Adults 18 years of age or older.

• Severe-to-profound, bilateral sensorineural hearing loss (≥ 70 dB HL).

• Postlingual onset of severe or profound hearing loss.

• Limited benefit from appropriately fitted hearing aids, defined as scoring 50% or less on a test of open-set sentence recognition (HINT Sentences). Children 12 months through 17 years of age.

• Profound, bilateral sensorineural deafness (≥ 90 dB HL).

• Use of appropriately fitted hearing aids for at least 6 months in children 2 through 17 years of age, or at least 3 months in children 12 through 23 months of age. The minimum duration of hearing aid use is waived if x-rays indicate ossification of the cochlea.

• Little or no benefit from appropriately fitted hearing aids. In younger children (< 4 years of age), lack of benefit is defined as a failure to reach developmentally appropriate auditory milestones (such as spontaneous response to name in quiet or to environmental sounds) measured using the Infant-Toddler Meaningful Auditory Integration Scale or Meaningful Auditory Integration Scale or ≤ 20% correct on a simple open-set word recognition test (Multisyllabic Lexical Neighborhood Test) administered using monitored live voice (70 dB SPL). In older children (≥ 4 years of age), lack of hearing aid benefit is defined as scoring ≤12% on a difficult open-set word recognition test (Phonetically Balanced-Kindergarten Test) or ≤ 30% on an open-set sentence test (Hearing In Noise Test for Children) administered using recorded materials in the soundfield (70 dB SPL).

Unilateral Hearing Loss The HiResolution™ Bionic Ear System is indicated for individuals with unilateral hearing loss who meet the following criteria:

Asymmetric Hearing Loss (AHL) Individuals with AHL are defined as those with a mild to moderately severe hearing loss in the better ear, i.e., a 4PTA of 31 to 65 dB HL at 500 Hz, 1000 Hz, 2000 Hz and 4000 Hz, with a difference of at least 15 dB in the 4PTA between ears.

It is recommended that individuals with AHL have at least two (2) weeks experience wearing an appropriately fitted Contralateral Routing of Signal (CROS) system or suitable hearing device prior to cochlear implantation. The ear to be implanted will be as follows:

Adults (18 years of age or older):

• Severe to profound sensorineural hearing loss (4PTA of 500, 1000, 2000, and 4000 Hz ≥ 80 dB HL)

• A score of ≤ 20% on a Consonant-Nucleus-Consonant (CNC) word test

Children (5 years through 17 years of age):

• Profound sensorineural hearing loss (4PTA of 500, 1000, 2000, and 4000 Hz ≥ 90 dB HL)

• Insufficient functional access to sound in the ear to be implanted must be determined by aided speech perception test scores of 5% or less on a developmentally appropriate monosyllabic word list when tested in the ear to be implanted alone.

Single-Sided Deafness (SSD) Individuals with SSD are defined as those with normal hearing or mild sensorineural hearing loss in the better ear (4PTA of ≤ 30 dB HL at 500, 1000, 2000, and 4000 Hz).

It is recommended that individuals with SSD have at least two (2) weeks experience wearing an appropriately fitted Contralateral Routing of Signal (CROS) system or suitable hearing device prior to cochlear implantation. The ear to be implanted will be as follows: Adults (18 years of age or older):

• Severe to profound sensorineural hearing loss (4PTA of 500, 1000, 2000, and 4000 Hz ≥ 80 dB HL)

• A score of ≤ 20% on a Consonant-Nucleus-Consonant (CNC) word test Children (5 years through 17 years of age):

• Profound sensorineural hearing loss (4PTA of 500, 1000, 2000, and 4000 Hz ≥ 90 dB HL)

• Insufficient functional access to sound in the ear to be implanted must be determined by aided speech perception test scores of 5% or less on a developmentally appropriate monosyllabic word list when tested in the ear to be implanted alone.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 6, 2026